- $1.04bn
- $1.20bn
- $440.59m
- 85
- 54
- 67
- 77
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 413 | 383 | 276 | 356 | 441 |
Cost of Revenue | |||||
Gross Profit | 176 | 162 | 113 | 139 | 185 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 364 | 351 | 269 | 320 | 385 |
Operating Profit | 48.5 | 32.7 | 7.41 | 35.8 | 55.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 33.1 | 17.1 | -0.644 | 28.4 | 49.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 22.1 | 11.9 | 0.877 | 20.1 | 33.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 22.8 | 11.9 | 0.877 | 20.1 | 33.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 22.8 | 11.9 | 0.877 | 20.1 | 33.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.655 | 0.36 | 0.069 | 0.604 | 1.17 |